NDC Active Ingredient Tafenoquine Succinate
Active Ingredient Information
What is the usage for Tafenoquine Succinate?
Tafenoquine is used in combination with another medication (such as chloroquine) to treat and prevent the return of malaria. Malaria is caused by infection with a parasite spread by mosquito bite. After they multiply and grow, the parasites infect your red blood cells and cause symptoms of malaria (such as fever, chills, sweating, headache, other flu-like symptoms). This medication works by stopping the growth of the parasite that causes malaria.
How many products in the NDC database contain Tafenoquine Succinate?
The NDC database has 2 products with the active ingredient Tafenoquine Succinate. The following table lists all the products that have this active ingredient.
NDC Products with Tafenoquine Succinate
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0173-0889 | Proprietary Name: Krintafel | Tafenoquine Succinate | Tablet, Film Coated | Oral | Glaxosmithkline Llc | ACTIVE | |
69766-079 | Proprietary Name: | Tafenoquine Succinate | Powder | Msn Life Sciences Private Limited | ACTIVE |